Fatemeh Khanizadeh1, Asghar Rahmani2, Khairollah Asadollahi3, Mohammad Reza Hafezi Ahmadi4. 1. Obstetrician/Gynecology, Shahid Beheshti University of Medical Science, Tehran, Iran. 2. Ilam University of Medical Science, Ilam, Iran. 3. Clinical epidemiology, Departament of Social Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran. 4. Department of Pathology, Ilam University of Medical Science, Ilam, Iran.
Abstract
OBJECTIVE: This study evaluated the effects of combination therapy of curcumin and alendronate on BMD and bone turnover markers in postmenopausal women with osteoporosis. SUBJECTS AND METHODS: In a randomized, double-blind trial study, 60 postmenopausal women were divided into three groups: control, alendronate, and alendronate + curcumin. Each group included 20 patients. Total body, total hip, lumbar spine and femoral neck BMDs were measured by dual-energy X-ray absorptiometry (DXA) at baseline and after 12 months of therapy. Bone turnover markers such as bone-specific alkaline phosphatase (BALP), osteocalcin and C-terminal cross-linking telopeptide of type I collagen (CTx) were measured at the outset and 6 months later. RESULTS: Patients in the control group suffered a significant decrease in BMD and increased bone turnover markers at the end of study. The group treated with only alendronate showed significantly decreased levels of BALP and CTx and increased levels of osteocalcin compared to the control group. The alendronate group also showed significant increases in the total body, total hip, lumbar spine and femoral neck BMDs at the end of study compared to the control group. In the curcumin + alendronate group, BALP and CTx levels decreased and osteocalcin levels increased significantly at the end of study compared to the control and alendronate groups. BMD indexes also increased in four areas significantly at the end of study compared to the control and alendronate groups. CONCLUSION: The combination of curcumin and alendronate has beneficial effects on BMD and bone turnover markers among postmenopausal women with osteoporosis. Arch Endocrinol Metab. 2018;62(4):438-45.
RCT Entities:
OBJECTIVE: This study evaluated the effects of combination therapy of curcumin and alendronate on BMD and bone turnover markers in postmenopausal women with osteoporosis. SUBJECTS AND METHODS: In a randomized, double-blind trial study, 60 postmenopausal women were divided into three groups: control, alendronate, and alendronate + curcumin. Each group included 20 patients. Total body, total hip, lumbar spine and femoral neck BMDs were measured by dual-energy X-ray absorptiometry (DXA) at baseline and after 12 months of therapy. Bone turnover markers such as bone-specific alkaline phosphatase (BALP), osteocalcin and C-terminal cross-linking telopeptide of type I collagen (CTx) were measured at the outset and 6 months later. RESULTS:Patients in the control group suffered a significant decrease in BMD and increased bone turnover markers at the end of study. The group treated with only alendronate showed significantly decreased levels of BALP and CTx and increased levels of osteocalcin compared to the control group. The alendronate group also showed significant increases in the total body, total hip, lumbar spine and femoral neck BMDs at the end of study compared to the control group. In the curcumin + alendronate group, BALP and CTx levels decreased and osteocalcin levels increased significantly at the end of study compared to the control and alendronate groups. BMD indexes also increased in four areas significantly at the end of study compared to the control and alendronate groups. CONCLUSION: The combination of curcumin and alendronate has beneficial effects on BMD and bone turnover markers among postmenopausal women with osteoporosis. Arch Endocrinol Metab. 2018;62(4):438-45.
Authors: Andrew G Kunihiro; Paula B Luis; Jennifer B Frye; Wade Chew; H H Chow; Claus Schneider; Janet L Funk Journal: Mol Nutr Food Res Date: 2020-06-25 Impact factor: 5.914
Authors: Andrew G Kunihiro; Paula B Luis; Julia A Brickey; Jen B Frye; H-H Sherry Chow; Claus Schneider; Janet L Funk Journal: J Nat Prod Date: 2019-02-22 Impact factor: 4.050
Authors: Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Julia N Cheng; Paula B Luis; Claus Schneider; Janet L Funk Journal: J Nutr Biochem Date: 2021-08-15 Impact factor: 6.048
Authors: Hanie Kheiridoost-Langaroodi; Seyed Kazem Shakouri; Mahdi Amirpour; Amir Mehdi Iranshahi; Azizeh Farshbaf-Khalili Journal: J Family Reprod Health Date: 2022-03
Authors: Xueman Zhou; Wenxiu Yuan; Xin Xiong; Zhenzhen Zhang; Jiaqi Liu; Yingcheng Zheng; Jun Wang; Jin Liu Journal: Front Cell Dev Biol Date: 2021-11-30